# BOTOX® in the Treatment of Crow's Feet Lines in Japan

> **NCT01797081** · PHASE3 · COMPLETED · sponsor: **Allergan** · enrollment: 300 (actual)

## Conditions studied

- Lateral Canthus Rhytides
- Crow's Feet Lines

## Interventions

- **BIOLOGICAL:** botulinum toxin Type A (24 U)
- **BIOLOGICAL:** botulinum toxin Type A (12 U)
- **OTHER:** Normal Saline

## Key facts

- **NCT ID:** NCT01797081
- **Lead sponsor:** Allergan
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-01-31
- **Primary completion:** 2013-07-18
- **Final completion:** 2014-07-07
- **Target enrollment:** 300 (ACTUAL)
- **Last updated:** 2019-04-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01797081

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01797081, "BOTOX® in the Treatment of Crow's Feet Lines in Japan". Retrieved via AI Analytics 2026-08-18 from https://api.ai-analytics.org/clinical/NCT01797081. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*